巴西专利BR112012008891B1 DEVICE FOR ADMINISTRATION OF MEDICATION ACTIVATED WITH THE PALM OF THE HAND

专利PDF首页>>巴西专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
medicine application device activated with the palm of the hand. the present invention relates to a device for parental application of a medication, such as a medicament. the device includes an upper compartment and a lower compartment, the upper compartment being configured to move in relation to the lower compartment as a result of applying external force to allow the user of the device to control the rate at which the drug is administered .
公开号:BR112012008891B1
申请号:R112012008891-2
申请日:2010-10-15
公开日:2021-04-13
发明作者:Lorin P. Olson；Peter Krulevitch；James Glencross；Jingli Wang；Nicholas Foley；Mingqi Zhao
申请人:Janssen Biotech, Inc.；
IPC主号:

专利说明:

[0001] This claim claims priority benefits under 35 USC§ 119 and / or §120 of US provisional deposited applications with serial number 61 / 361,983, filed on July 7, 2010, and 61 / 252,378, filed on 16 October 2009, whose orders are hereby incorporated by reference in their entirety for reference. FIELD OF THE INVENTION
[0002] The invention relates, in general, to methods and devices for parenteral application of drugs. The devices provide assisted manual drug delivery with confirmation of completion of the drug delivery process. The devices provide a system with enhanced security and ease of use, in addition to audible feedback, or in other ways, to the user to indicate when drug application is in process, completed, or both, to avoid one or both of incomplete dosing and wasted medication, as well as to provide a system with enhanced safety and ease of use. BACKGROUND OF THE INVENTION
[0003] For many years, an accepted method for parenteral application of drugs has been through the use of a syringe and needle. The syringe contains an amount of a drug sold in a pre-filled syringe or introduced into a syringe by extracting the drug in a syringe from a vial or other container. Syringes have been widely accepted due to their low cost, simplicity of manufacture and effective design. For the user, however, syringes and needles have several disadvantages.
[0004] A disadvantage is that many patients are afraid of needles. In instances where self-medication is required, such as those that require multiple daily injections, patients cannot administer their medication according to their prescribed regimen due to fear of needles, the pain that is often associated with an injection, the dexterity that is required to properly administer a drug via needle and syringe or other similar factors. For some, who have impaired their vision, dexterity or conscience, self-administration through needle and syringe can present additional difficulties that prevent them from receiving the required medication.
[0005] There are also concerns about safety and disposal associated with needles and syringes not only for the patient, but for those around them that may result from contaminated needles, accidental punctures, cross-contamination, and the like, in addition to the social stigma associated with a drug treatment regimen using a needle and syringe. Despite these disadvantages, however, many patients are encouraged to use needles and syringes for the application of their drug due to the ability to control needle insertion and the speed of drug delivery when the plunger in the syringe is pressed and, therefore, to control their perception of pain and discomfort associated with this type of drug injection.
[0006] Several advances have been made over the years to help facilitate self-administration of medication. Such advances include smaller needles with improved tip geometry to reduce pain. Safety syringes that closed the needle before, after or before and after use were used to minimize concerns about accidental needle punctures. The improved ergonomics of the syringe design have also been promoted to reduce the dexterity required to accurately and safely administer medication through the needle and syringe. Pre-filled disposable devices, having a pen-like forming factor, were developed to optimize dosing accuracy and auto-injectors were used to hide the needle from the patient to reduce fear and safety concerns by both needle retraction and by placing a shield around the needle.
[0007] Although some advances have improved needle and syringe-based drug application, ergonomic designs, pens and autoinjectors retain a substantial similarity to the original needle and syringe concept, thus limiting their acceptance by patients who need to self-administer your medication. Current systems employ a forming factor that suggests the "pick and drill" injection technique, with the user taking the device in the palm of their hand and placing their thumb over an activable button.
[0008] Current autoinjectors transfer control of drug application in the body to a mechanical system. As such a system is highly dependent on the specific mechanical design of the autoinjector, patients may require specialized training to use the device and there is still the risk of unnecessary dosing. This situation is highly problematic when it releases very expensive drugs that could only be administered weekly or even more infrequently.
[0009] The typical method of using current autoinjectors includes the patient holding the device against the skin for several seconds while the device is in the process of drug delivery. Many users, and the elderly in particular, may experience fatigue in the arm or hand causing them to exert uneven pressure from the device against the skin, or they may remove the device prematurely. Either situation can result in inaccurate dosing, wasted drug, increased discomfort, and the like. Under any of these circumstances, current devices and methods that include, or have evolved from, the traditional syringe and needle system, have deficiencies that compromise the effectiveness of a prescribed drug regimen.
[00010] Finally, as with any health care-related device or service, the cost of any component used frequently in a treatment regimen needs to be considered. While providing drugs in vials that are used to fill empty syringes when, or around, the patient's drug time, it can provide the least expensive solution, adding an additional opportunity for the waste or loss of an expensive drug. If this drug requires refrigeration, it may suffer degradation each time it is removed and reinserted into the refrigeration device before and after filling the syringe, which can lead to less than expected drug effectiveness if the vial contains an amount of drug that is applied over a long period of time. Although pre-filled syringes offer an advantage in both reliability and convenience, such devices still have inherent disadvantages mentioned above.
[00011] With devices such as pre-filled autoinjectors, the device is most commonly manufactured for use with a wide variety of medications, most not customized for a drug. As such devices rely on mechanical systems using springs to control the rate of drug injection, many drugs of different viscosities or which require refrigeration and change of viscosity as an appreciable result of the change in temperature, the drug can be applied very quickly or very slowly, according to the predetermined spring force of the self-injector design. In many instances, too low a spring force can result in incomplete drug delivery, removal of the device before application is completed, or excessive pain and discomfort for the user resulting from a prolonged period during which the injection device is inserted on body. Too high a spring force, however, can result in drug delivery that is so fast that it degrades the drug, or it can cause pain of injection force to the patient caused by the rapid application of an acidic drug or inducing a pressure gradient under the skin or in a vein.
[00012] Thus, there are many opportunities for advancing in the field of parenteral and episodic drug application, with parenteral drug application being able to overcome "needle phobia", reduce patient pain and increase the safety, reliability and efficacy of many drug treatment regimens. BRIEF DESCRIPTION OF THE DRAWINGS
[00013] Figure 1A is a side view of an embodiment of the present invention.
[00014] Figure 1B is a side view of the embodiment of figure 1A after removing the cover.
[00015] Figure 1C is a side view of the figure 1B mode after pressing the locking button.
[00016] Figure 1D is a side view of the embodiment of figure 1C after the needle guard has been retracted, exposing the needle.
[00017] Figure 2A is a side view of the embodiment of figure 1D during the injection of the drug.
[00018] Figure 2B is a side view of the embodiment of figure 2A upon completion of the drug injection.
[00019] Figure 2C is a side view of the modality of figure 2B after the needle guard has been extended, hiding the needle,
[00020] Figure 3 is a representation of an exploded view of the embodiment of figure 1A.
[00021] Figure 4 is a representation of a cross-sectional view of the modality of figure 1A.
[00022] Figure 5 is a representation of a partial cross-sectional view of a portion of the embodiment of Figure 1A, representing a lock.
[00023] Figure 6 is a partial cross-sectional view of a portion of the embodiment of Figure 1A, representing a lock.
[00024] Figure 7 is a representation of a cross-sectional view of the embodiment of figure 2A.
[00025] Figure 8 is a representation of a cross-sectional view of the embodiment of figure 2B.
[00026] Figure 9 is a representation of the cross-sectional view of the modality of figure 2C
[00027] Figure 10A is a side view of another embodiment of the present invention.
[00028] Figure 10B is a side view of the embodiment of figure 10A after removing the cover.
[00029] Figure 10C is a side view of the embodiment of figure 10B after the needle guard has been retracted, exposing the needle.
[00030] Figure 11A is a side view of the embodiment of figure 10C during the injection of the drug.
[00031] Figure 11B is a side view of the embodiment of figure 11A upon completion of the drug injection.
[00032] Figure 11C is a side view of the embodiment of figure 11B after the needle guard has been extended, hiding the needle.
[00033] Figure 12 is a representation of an exploded view of the embodiment of figure 10A.
[00034] Figure 13A is a perspective view of the lower compartment of the embodiment of figure 10A.
[00035] Figure 13B is a perspective view of the intermediate part of the compartment of the embodiment of figure 10A.
[00036] Figure 14 is a representation of a partial cross-sectional view of a portion of the upper and intermediate compartments of the embodiment of figure 10A.
[00037] Figure 15 is a representation of a locking mechanism in the form of figure 10A.
[00038] Figure 16 is a representation of another locking mechanism of the modality of figure 10A.
[00039] Figure 17A is a representation of a cross-sectional view of a portion of the embodiment of figure 10A.
[00040] Figure 17B is a representation of a perspective view of a portion of the lower compartment of the embodiment of figure 10A.
[00041] Figure 18 is a cross-sectional view of the device in Figure 10A.
[00042] Figure 19 is an exploded side view of yet another embodiment of the present invention.
[00043] Figure 20 is a representation of a side view in cross section of yet another embodiment of the present invention before use.
[00044] Figure 21A is a perspective view of an alternative design of the lower compartment of the embodiment of figure 10A.
[00045] Figure 21B is a perspective view of an alternative embodiment of the lower compartment of figure 10A.
[00046] Figure 21C is a cross-sectional view of the lower compartment of figure 21B. DETAILED DESCRIPTION OF THE INVENTION AND PREFERENTIAL MODALITIES
[00047] The detailed description to be read with reference to the drawings in which the same elements in different drawings are numbered identically. The drawings, which are not necessarily to scale, represent exemplary modalities for the purpose of explanation only, and are not intended to limit the scope of the invention. The detailed description illustrates, by way of example, and not by way of limitation, the principles of the invention.
[00048] The present invention is a device for applying drugs and methods for its use, the device of which resolves many of the limitations and disadvantages of traditional syringes and needles, as well as those of the auto-injector type devices. To overcome the disadvantages and limitations of the previous devices and to address unmet needs in the art, the device modalities and methods currently presented include a device that is configured so that the user cannot see and cannot touch the needle, reducing phobia by needle and the potential for needle contamination. This includes automatic needle protection after drug application.
[00049] The modalities of the device have an ergonomic shape factor that allows one-handed operation and allows, in a convenient way, injections in alternative places, such as in the leg, arm or abdomen. In embodiments that include a pressure sensitive activator, a needle guard lock inhibits needle movement. In this way, the device includes a safety mechanism that will not allow the needle to be exposed if it is not pressed against the injection site.
[00050] In figures 1A-1D, a device embodiment of the invention is illustrated that includes a window 104 for viewing the drug before use. A colored indicator may appear in the window after the device has been used, to provide a visual indication to the user that the device's drug has been used. In addition, after the drug is applied, increased safety and reduced chance of accidental needle punctures are provided.
[00051] To ensure that the user is aware of the status of the drug application and whether it is completed, this modality of the invention includes tongues and turnstiles, such as those illustrated by tongues 117 and turnstiles 116 shown in figures 4 and 7 , which engage to produce one or more audible clicks when the injection is complete. Such a mechanism can signal to the user that the dose has been applied and that the device can be removed from the skin, preventing premature removal of the device from the injection site. Thus, the user actively participates throughout the delivery process, unlike conventional auto injectors, in which the user may need to wait several seconds to be sure that the entire dose has been administered.
[00052] To provide greater feedback to the user, the presented system of tongues and turnstiles also provides audible clicks and movement of the device during application to indicate that the injection is proceeding. In yet another modality, a higher click at the end of the application, alone or in combination with a visual indicator, provides 1 feedback confirming that the application is complete.
[00053] In addition, the present invention has a non-intimidating and friendly design and method of operation, unlike conventional needle devices and autoinjectors, which are reminiscent of syringes and cause discomfort to the user. Additionally, unlike autoinserts, the user controls the insertion of the needle and injection of the drug as described from this point on in this document.
[00054] In figures 1 to 9, an exemplary device of the invention is shown. In figures 1A to 1D a device modality is shown, in several stages, leading to the injection of the drug and in figures 2A to 2C the modality is shown during and after the injection of the drug. Figure 1A shows the device 100 in its pre-use configuration as it can be received by the user. In this relaxed position, the upper compartment 101 partially overlaps the proximal or more upper portion of the lower compartment 102. In describing the various modalities of the device, the term proximal is used in relation to the bottom surface of the device. For example, in figure 1B, the proximal is used in relation to the bottom or bottom surface 131 of the device 100.
[00055] As shown, the visible external features include upper compartment 101, lower compartment 102, cover 103, window 104, interlock button 105, handle ring 106, bottom edge 111 of upper compartment 101 and dose indicator 107. A figure 3 is an exploded view of the components of this embodiment of the invention.
[00056] A preliminary step in using the device is to remove the cover 103, which is removably attached to the lower compartment 102, as shown in figure 1B. Removing the cap 103 simultaneously removes the needle guard 113 and exposes the needle guard 108. The window 104 and the needle guard slot 109, each of which is preferably present on both sides of the device, allow the user to view and inspecting an internally stored syringe 118 and the drug content.
[00057] In use, the device is picked up by placing the palm of the hand over the top of the upper compartment 101, similar to how someone picks up an automotive gearshift mounted on the floor. The grip ring 106 provides a visual signal to the user on how to pick up the device. In one embodiment, the grip ring 106 is covered, or coated, or is made from a suitable elastomeric material including, without limitation, neoprene rubber, urethane, polyurethane, silicone, natural rubber, thermoplastic elastomer ("TPE") , or combinations thereof to provide a non-slip and comfortable grip surface.
[00058] The user presses the device, by pressing down the palm on the grip ring 106 and interlock button 105, against the body at the desired injection site, typically the top or the side of the upper leg, the abdomen, or the side or back of the upper arm. The pressure of the palm on the interlock button 105 causes it to deflect downwards, as shown in figure 1C, which, in turn, releases the needle guard lock 124, shown in figure 5, allowing the needle guard 108 to slide to above and exposing the needle 110 (note that some components of the device have been removed from figure 5 for purposes of illustration). The needle guard lock 124 is integrally formed with a portion of the distal end of the upper compartment sleeve 120. The upper compartment sleeve 120 is a hollow cylinder, a portion of which resides in the upper compartment 101 and a portion of which resides in the upper compartment. upper compartment 102 when the device is in the relaxed position. The upper compartment sleeve 120 is fixedly attached to the upper compartment 101 and performs the locking functions and acts to secure the changing element 119 against the upper compartment 102, as described in more detail below.
[00059] The needle guard lock 124 includes, facing forward with respect to the longitudinal central axis A-A 'of the device, an inclined surface 127 and lock 130 at its uppermost end. To release the needle guard latch 124, an outward sloping surface 128, complementary to surface 127, which forms the distal end of the extension of the interlock button 123, engages the inclined surface 127 in the needle guard latch 124 The engagement of surfaces 127 and 128 causes the needle guard lock 124 to deflect outwardly with respect to the central axis, removing the lock 130 of the upward movement of the needle guard 108. The locking mechanism and guard needle 108 are preferably configured so that the upward movement of the needle guard 108 is avoided, unless the interlock button 105 is fully depressed. This protects the needle from contamination and damage due to contact with other surfaces, protects the user from accidental needle punctures and hides the needle.
[00060] As the user continues to press down on the upper compartment 101, needle guard 108 moves upwards, exposing and allowing needle 110 to penetrate the user's skin, stopping when the lower surface 131 of the compartment upper 102 is substantially placed against the skin. Once the needle guard 108 passes beyond the lock 130, the user can release the interlock button 105, or choose not to, without affecting the other steps of the injection. When interlock button 105 is released, resilient member 121 returns interlock button 105 to the upper position. The movement guide 132 acts to ensure that the interlock button goes straight up and down.
[00061] The needle insertion process described here provides insertion control for the user. This feature allows the user to take advantage of a commonly used method, often used for insulin-dependent diabetics: if the needle is placed in contact with the skin and remains there without penetrating the skin, after a few seconds the user will no longer feel the presence of the needle, at the point where the needle can be inserted painlessly by increasing the pressure applied to the needle.
[00062] After needle 110 has been inserted into the user, the injection process typically begins, as shown in figures 2A to 2C. With reference to figure 6, the lock of compartment 122, which is part of the upper compartment 102, is shown in close-up and prevents the upper compartment 101 from moving in relation to the upper compartment 102 in the pre-use state of the device (note that some components of the device have been removed from figure 6 for purposes of illustration). When the needle guard 108 has completed its upward trajectory, the inclined surface 133 in the needle guard 108 comes into contact with an inclined portion of the surface 134 that forms the end of the compartment 122 latch, causing the latch of the compartment 122 to be deflected inwardly, thus allowing the upper compartment 101 and the upper compartment sleeve 120 to move downwards.
[00063] After inserting the needle 110 into the body, the user maintains pressure on the upper compartment 101. As shown in figures 3, 4, 7 and 8, a plunger rod 115 pushes a plunger 112. The plunger rod 115 is fixedly connected to the upper compartment 101 and the syringe 118 is attached or held in a cylinder formed inside the upper compartment 102. Thus, when the upper compartment 101 moves downwards in relation to and over the upper compartment 102, a drug inside the syringe 110 it is applied through the needle 110 to the patient by the downward movement of the plunger rod 115 and the plunger 112 inside the syringe 118.
[00064] After the compartment latch 122 is disengaged, an altering element 119 surrounding the distal end of the upper compartment sleeve 120 is released from a tensioned state to apply a downward force to the upper compartment 101 by exerting a downward force on the upper compartment sleeve 120, which is fixedly attached at its uppermost end, to the upper compartment 101. The changing element 119 can also be used to supply energy to assist the advancement of the plunger rod 115 and plunger 112 , with the user providing the additional required force resulting in injection of the drug or the energy supplied by the changing element 119 may be sufficient only to advance the plunger rod 15 and the plunger 112. In another embodiment of the present invention, the element modification 119 provides sufficient force to inject the drug, without additional force input required by the user, thus providing an injection device in the which the needle is manually inserted and the drug is automatically injected. The changing element can be any component capable of exerting a downward force on the upper compartment sleeve 120 to the desired degree and can be, without limitation, a spring, a compressed gas actuator, a hydraulic actuator, a wax actuator, an electrochemical actuator, an alloy with format memory, and the like, and combinations thereof. In the mode shown in figures 1 to 9, the user provides the additional force required to advance the plunger rod 115 and plunger 112 by pressing down on the upper compartment 101. Thus, the force required by the user to inject the drug is reduced, analogous to the way that the hydraulic steering of a car reduces the force required of the driver to turn the steering wheel. Unlike conventional auto-injectors, the user contributes the strength required for the injection and the present invention provides the user with control over the injection rate of the drug.
[00065] With reference to figures 4 and 7, the cross-sectional views of the modalities of the present invention are shown before and after the drug application has started, respectively. As the drug is being applied, a tongue 117 that is attached to the sleeve of the upper compartment 120 moves along a ratchet 116 that is attached to the upper compartment 102. The tongue 117 and the ratchet 116 can carry out at least , the following two functions. The first is to avoid separating the upper compartment 101 from the lower compartment 102 by pulling them out. Second, the movement of the tongue 117 along the ratchet 116 produces a soft clicking noise, providing feedback to the user that the upper compartment 101 is in motion and the drug is being applied. Additionally, and as illustrated in figure 8, at the end of the upper compartment 101, the tongue 117 can be configured to engage a deeper recess in the ratchet 116, thus producing a louder click sound, which can provide an audible signal for the user that the end of the route has been reached and the drug has been fully applied, and additional locking of the upper compartment 101 is done to avoid reconfiguring or reusing the device.
[00066] With reference to figures 2B and 8, when the drug is completely injected and the upper compartment 101 is at the end of its course, the lower edge 111 of the upper compartment 101 covers the dose indicator 107. The dose indicator 107 is a colored circumferential ring in the distal portion of the lower compartment 102. This provides a visual signal to the user that the drug application has been completed.
[00067] Before use, the patient can view the drug through window 104 to inspect it for clarity and particulates. After use, plunger 112 can be seen in window 104, indicating that the device has been used. Alternatively, the window can be designed so that the plunger rod 115 is also visible after the injection is complete. Plunger 112 and plunger rod 115 may be brightly colored to provide a clear indication to the patient that the device has been used.
[00068] With reference to figures 2C and 9, after completing the injection, the user removes the device 100 from the skin, and the needle guard return element 114 causes the needle guard 108 to extend over the needle 110, protecting the user and others from accidental needle punctures. The return of the needle guard can be any element capable of making the needle guard 108 extend over the needle 110 including, without limitation, a spring, a compressed gas actuator, a hydraulic activator, a wax actuator, an electrochemical driver, an alloy with format memory and the like, and combinations thereof. Once the needle guard 108 is fully extended, a needle guard lock 125 engages a slot in the needle guard 108, preventing it 108 from retracting. The needle guard lock 125 is a cantilever lock that extends inwardly from the inner surface of the upper compartment sleeve 120. The rib of the lower compartment 126, a part of the lower compartment 102, can be configured to prevent the lock needle guard 125 engages the needle guard slot 108 prematurely, during application, blocking the slot. In another embodiment of the present invention, needle guard 108 can extend and lock in place if device 100 is removed before application is complete, to prevent reuse or sharing of the device.
[00069] With the assisted application approach offered by the present invention, the user is actively safe during the entire application process. This is distinguishable from the activation process of conventional autoinserters, in which after pressing the button, the user passively waits, for several seconds, for the drug to be applied, sometimes wondering if the injection is in process or not.
[00070] The assisted activation approach of the present invention has the additional advantage of reducing the development time and the cost associated with modifying the injection device for the application of different drugs because the user controls the speed of application by varying the force applied to the upper compartment 101. If the plunger becomes slightly stuck, the user can apply a little more force, unlike conventional autoinjectors that need to be designed for the worst case strength requirements, which vary depending on the drug, cartridge, plunger, needle and friction in the mechanism.
[00071] In another embodiment, the interlock button 105 and the interlock spring 121 can be omitted from the design. In this embodiment, the upper compartment 101 is free to move downward before reaching a lock. This movement is used to release the needle guard 108 using a mechanism similar to the interlock mechanism described above, allowing the needle guard 108 to retract. Once the needle guard 108 is fully retracted, it can disengage another lock that allows the upper compartment 101 to stop the downward movement and inject the drug in a similar manner as described above.
[00072] In figures 10 to 18, yet another embodiment of the invention is shown. In figure 10A there is shown the device 200 with the upper compartment 205, the lower compartment 202 and the intermediate compartment 201 between them. The upper compartment 205 includes the handle cover 228. In the relaxed position, the upper compartment 205 partially overlaps the proximal portion of the intermediate compartment 201. The most distal portion of the intermediate compartment 201 is fixedly seated in the lower compartment 202. It is also shown in figure 10A the lower edge of the upper compartment 211, the crest of the path 216 and the window 204. The window 204 is preferably housed within the proximal portion of the lower compartment 202. A second window, preferably not shown, is present on the device on the opposite side of window 204.
[00073] The cover 203 is removably attached to the lower compartment 202 and, in figure 10B, it is shown removed from the device 200 to expose the needle guard 213, the needle guard claw 217 and the needle guard 208. During removing the cap 203, the needle guard 217 grips and simultaneously removes the needle guard 213 exposing the needle guard 208 to the user. When the user of the device presses the needle guard 208 against the skin, this action causes the needle guard 208 to slide upwards exposing the needle 210, as shown in figure 10C.
[00074] Figure 12 is an exploded view of the device 200. The handle cover 228 includes the pins of the handle cover assembly 230 that securely holds the handle cover 228 in the upper compartment 205. The pins of the assembly 230 match with the holes 242 in the upper compartment 205. Preferably, the pins of the set 230 are square in the cross section with rounded corners providing an interference surface between the corners of the pins of the set 230 and the holes 242. The guides 233 and the stem of the plunger 215, which are integral with and extend downwardly from the inner surface of the handle cover 228 are shown. The piston rod 215 includes a damper 221 at its distal end. Also shown is syringe 218 with plunger 212 and needle guard 213.
[00075] In a preferred embodiment, the outer surface of the handle cover 228 is coated with or formed from, or the entire handle cover 228 is formed from a material capable of providing a soft and non-slip handle for the user. Suitable materials for coating or forming the handle cover include, but are not limited to, elastomeric materials such as neoprene rubber, urethane, polyurethane, silicone, natural rubber, TPE and the like and combinations thereof.
[00076] The upper compartment 205 includes click lock 220, cable rib guide 238, and bottom edge 211. For click lock 220, as well as the other locks used on the device, preferably at least two locks are used and the same locks are symmetrically positioned relative to each other to facilitate smooth movement and operation of the device.
[00077] The intermediate compartment 201 is shown in figure 12 with guide slots 239 of the body 207 and cable on the outer surface of the proximal portion of the body 207. When the device is in use, the cable rib guides 238, which are part part of the upper compartment 205, engage and slide into the slots in the cable guide 239, maintaining the smooth and controlled movement of the upper compartment 205 during the application of the drug.
[00078] Body 207 can serve as a dose indicator because, when the device is activated, the upper compartment 205 descends over body 207. When the full dose of drug is applied, body 207 is completely obscured by the upper compartment 205 as shown in figure 11C. Preferably the 207 body is colored, more preferably with a bright color, or is provided with a pattern to provide visual feedback easily seen by the user that the dosage is in progress or has been completed. Optionally, a scale can be included in body 207 to visually quantify the amount of the drug that has been applied or to be applied.
[00079] With reference to figure 13, the intermediate compartment 201 also includes handle latches 224, handle catch slots with click 236, and needle guard latch 237. Handle latch 224 is generally a rectangular element fixed in place. movable way to its most distal portion of the inner surface 243 of the intermediate compartment 201 so that it is able to move outwardly towards the inner surface 243 by applying force. The handle lock 224 also includes a locking surface 245 and a triangular lock 244 extending inwardly towards the center of the device from a corner of its uppermost portion. On the rest of the device, the handle lock 224 in the pre-use position prevents the upper compartment 205 from moving in relation to the intermediate compartment 201 due to the lock 245 that interferes with the downward path of the tabs 233 of the handle cover 228.
[00080] With reference to figures 12 and 13, the lower compartment 202 is shown with the base of the lower compartment 206, the crest end of the path 216, the window 204, the lock of the compartment 229, the slots of the guide 227 and the clip syringe retainer 235. Cap 203 removably attaches to the bottom of the bottom compartment 206 through the cap retainer ring 234. In use, the bottom of the bottom compartment 206 comes into contact with the user's skin and thus preference is produced from any soft flexible materials suitable for use in the handle cover 228.
[00081] Window 204 provides an opening system in the lower compartment 202 for viewing the contents of syringe 218. Window 204 is positioned so that the bottom of syringe 218 is visible to the user, allowing the user to check whether the plunger 212 reached the end of his journey to the bottom of the syringe. Window 204 can be of any convenient size and shape and is preferably oblong in shape, with its long axis aligned with the long axis of the device and the syringe so that the desired length of the syringe is exposed for viewing.
[00082] The slots in the guide 227 maintain the alignment of three different components: guides 233 of the handle cover 228, release of the handle lock 231 and extensions of the needle guard 241. The slits of the guide 227 ensure smooth activation of the device maintaining the alignment and vertical path of the upper compartment 202 and the needle guard 208 and reliable locking and unlocking of the handle lock 231. The lock of the compartment 229 extending outwards secures the intermediate compartment 201 to the lower compartment 202 by engaging in a recess , which is not shown, on the inner surface 243 of the intermediate compartment 201. In the non-reusable embodiments of the device, the shape of the lock 229 and the recess are such that the lower and intermediate compartments cannot be separated. For reusable modes, the recess and lock are configured to allow the lower and intermediate compartments to be separated.
[00083] With reference to the figure. 12, the needle guard 208 includes the slot of the needle guard 209 formed on one side by the release of the handle lock 231 and on the other side by the extension of the needle guard 241. The release of the handle lock 231 includes an inclined surface 240. Referring to Figures 14 and 15, the inclined surface 240 of the handle latch release 231 faces outward and, as handle latch 231 travels upward, engages with the inclined surface 244 of the handle latch 224, which faces inward, causing the handle lock 224 to deflect outwardly, removing the obstruction for the downward movement of the guide 233 and 205.
[00084] The needle guard slot 209 allows window 204 to be used to view the syringe and plunger since the plunger acts on the syringe at the end of the downward stroke of the plunger. Additionally, the return of the needle guard 214 is inside and at the bottom of a space formed by the release of the handle lock 231 and the extension of the needle guard 241.
[00085] One aspect of the invention of device 200 is the way in which syringe 218 is suspended within the device. Referring to Figures 12, 13 and 17, syringe 218 is held between needle guard 213 and buffer 221, each of which is a flexible component to protect syringe 218 in the event that device 200 falls or is otherwise handled wrong. When the device is assembled, the syringe 218 is held loosely inside the cavity 246 of the lower compartment 202 by retaining claws 235. Depending on the volume of drug inside the syringe 218, when the device is in use, there may be some path from the compartment upper 205 before shock absorber 221 contacts plunger 212 and, during this initial downward travel, shock absorber 221 acts as an air piston to compress air in the gap formed between the end of piston rod 215 and plunger 212 , which provides a rate-dependent resistance to move under the handle initially. When the damper 221 moves quickly, the air cannot escape quickly enough to reduce the build-up of air pressure. The damper 221 can optionally include through-holes, which are not shown, which allow air to leak after the damper 221. Alternatively, a damper-based resistance of the damper without build-up, uses a damper in which there is no leakage and no dependence at the rate or combinations of them can be used. Upon contact of the shock absorber 221 with the piston 212, the shock absorber 221 retracts inwardly towards the piston rod 215 reducing the friction between the shock absorber 221 and the internal surface of the cavity 246.
[00086] With reference to figures 10 and 11, when the user wishes to use the device 200, the user removes the cover 203 of the lower compartment 202, whose action simultaneously removes the needle protection 213 and exposes the needle guard 208. The user take the device 200 by the upper compartment 205, place it in the palm of the hand on the handle cover 228 and press down on the handle cover 228, while holding the device 200 against the desired injection site in the body, whose action of pressure causes the needle guard 208 to slide upwards exposing the needle 210. Applying continuous pressure to the handle cap 228 results in the needle 210 penetrating the user's skin and subdermal tissue, interrupting when the bottom of the lower compartment 206 comes into contact contact with the skin surface or when the flap 245 reaches the guard of the needle 208 and reaches the end of its path inside the lower compartment 202.
[00087] With reference to figure 15, when the needle guard 208 reaches the end of its path upwards inside the lower compartment 202, the inclined surface 240 of the release of the handle lock 231 comes into contact with the inclined ramp 244 of the lock handle 224 facing opposite and complementary to the intermediate compartment 201 causing the handle lock 224 to deflect towards the inner wall 243 of the intermediate compartment 201. This action removes the locking surface 245 of the handle lock 224 from interference with the path for under the guide 233 of the handle cover 228, releasing the guide 233 and allowing the upper compartment 205 to move down and over the intermediate compartment 201.
[00088] When the upper compartment 205 moves downwards, the drug inside the syringe 218 is applied through the needle 210 as the plunger rod 215 and the buffer 221 of the handle cap 228 push down the plunger of the syringe 212 At the end of the drug application, the body 207 is substantially and completely covered by the upper compartment 205 and the lower edge 211 of the upper compartment 205 fits completely to the crest of the shaped path 216 of the lower compartment 202. Also the piston rod 215, the buffer 221 and plunger 212 are clearly visible within window 204. All of these features provide the user with visual confirmation that the drug has been applied and the end point of the bottom edge 211 against the crest of path 216 provides tactile confirmation for the user.
[00089] Additionally, a click mechanism is activated at the end of the drug application to provide audible feedback. With reference to figure 14, the click lock 220 is deflected out when the ramp 247 of the same comes into contact and slides on top of the intermediate compartment 201. When the ramp 247 moves sufficiently far down, the ramp 247 moves aligns with the capture slot of the click lock 236 and the ramp 247 slides into the capture slot 236, the slot extending through the wall in the proximal portion of the intermediate compartment 201, and makes a click against the outer surface of the body 207 of the intermediate compartment 201, creating a clicking sound. In non-reusable versions of the device, the click lock 220 is permanently captured by the capture slot 236 and cannot be readjusted. In a preferred embodiment, two click locks 220 are positioned at 180 degree positions in opposition to each other to provide smooth activation of the device and improved click and lock functions.
[00090] As the user removes the device 200 from the skin, the return of the needle guard 214, shown in figure 12 as a spring that was compressed by pressing the device 200 against the user's skin, expands by guarding the device. needle 208 extends downward over needle 210 protecting the user from accidental perforations. In addition to a spring, the return of the needle guard can be a compressed gas actuator, a hydraulic activator, a wax actuator, an electrochemical actuator, an alloy with shape memory, and the like and combinations thereof. When the needle guard 208 is fully extended, the needle guard retainer 232 engages with the lock 248, shown in figure 13, on the lower compartment 202 preventing the needle guard 208 from separating from the lower compartment 202. Figure 16 shows the needle guard lock 237 movably fixed at its distal end to the inner surface 243 of the intermediate compartment 201. When the needle guard 208 is moving upwards, the needle guard lock 237 is deflected out in contact with the outer surface of the guide 233 or the needle guard extension 241. When the needle guard 208 moves down and extends to the cap, the needle 210 and the needle guard lock 237 slide over the top of the needle guard extension 241 preventing the needle guard 208 from retracting again.
[00091] Before use, the extension guides 233 of the handle cover 228 retain the needle guard lock 237 in an outward deflecting position allowing the needle guard 208 to retract for needle insertion 210. The two needle guard retainers 232 and needle guard latches 237 are preferably used and located 180 degrees around the central axis of device 200. If device 200 is removed from the skin before medication is released complete, needle guard 208 will extend to cover needle 210 and lock to prevent reuse of the device. In an alternative reusable embodiment, the needle guard 208 extends, but is not locked in place if the device 200 is removed from the skin before the medication release is complete.
[00092] Figure 19 is a demonstration of an alternative and reusable modality of the device 200 in which the upper compartment 205 and the intermediate compartment 201 are separable from the lower compartment 202. In this modality, the user separates the lower and intermediate compartments, inserts syringe 218 in the lower compartment and then reattach the upper and intermediate compartments.
[00093] In figure 20 there is shown yet another alternative modality of the device 200 in which an assisted activator 219 is included. The assisted activator 219 can find its greatest utility in the application of viscous drugs. The assisted activator 219 applies a force between the upper compartment 205 and the intermediate compartment 201 by exerting a downward force on the sleeve of the upper compartment 120. This reduces the amount of downward force that the user needs to apply to the handle cover 228 to inject the drug. The assisted activator 219 can be a spring, an actuator, a hydraulic actuator, a wax actuator, an electrochemical actuator, an alloy with shape or similar memory or combinations thereof. Alternatively, the assisted activator can provide sufficient force to inject the drug, with no additional force input required from the user, thus providing an injection device into which the needle is manually inserted and the drug is automatically injected in a similar manner to a conventional autoinjector.
[00094] In figure 21 an alternative embodiment of the lower compartment 202 of device 200 is shown, in which a resettable click mechanism for a reusable device is included. In this embodiment, the slots in the guide 227 engage with the guide 2225 of the click element 222. The click device 222 is changed by the return of the needle guard 214. To adjust the click device 222, the user presses down on one of the guides from the click element 225 until the lock of the click element 226 extends over the click device 222 keeping it down. When the handle cover 228 moves downward at the end of the path, the guide 233 comes into contact with an inclined surface in the lock of the click element 226 causing it to deflect inward and releasing the click element 222 to make the upward path under the force of the needle guard return 214. A clicking sound is generated when the click surface 223 of the click element 222 comes into contact with the lower compartment 202 signaling that the drug has been fully applied. Compression of needle guard return 214 is released when needle guard 208 is retracted during drug injection, increasing the force applied to the click device and the volume of the click sound. Alternatively, the click mechanism can be readjusted automatically when the user attaches the upper compartment to the lower compartment by loading a new syringe into the device.
[00095] Additional modalities of the present invention can be envisaged, but are not included in the attached figures. This includes a multi-dose design in which one or both of the upper and intermediate compartments rise to a partial height and apply a partial syringe when pressed by the user.

权利要求:
Claims (23)
[0001]
1. Device for administering medication, the device characterized by the fact that it comprises: a lower compartment (202) having a lower surface and a syringe (218) that is configured to contain a medication in it; an intermediate compartment (201) attached to the lower compartment and comprising a body (207); an upper compartment (205) attached to the intermediate compartment (201) and configured to move along the intermediate compartment (201) towards the lower surface of the lower compartment (202) from a first position to a second position, where the intermediate compartment body (207) is exposed between the upper compartment (205) and the lower compartment (202) when the upper compartment (205) is in the first position, and the upper compartment (205) completely covers the body of the intermediate compartment (207 ) when the upper compartment (205) is in the second position; and a piston rod (215) supported by the upper compartment (205) so that the movement of the upper compartment (205) from the first position to the second position causes the piston rod (215) to advance with the upper compartment (205 ) in relation to the syringe (218), causing the syringe (218) to apply the medication.
[0002]
2. Device according to claim 1, characterized by the fact that the lower compartment (202) still comprises a needle guard (208), in which the needle guard (208) moves upwards to expose a needle ( 210) when the bottom surface of the lower compartment is pressed against a skin surface.
[0003]
3. Device according to claim 2, characterized by the fact that the needle guard (208) still comprises a return of the needle guard capable of extending the needle guard (208) over the needle (210) when the surface bottom of the lower compartment is removed from the skin surface.
[0004]
Device according to claim 1, characterized by the fact that the lower compartment (202) still comprises a first surface at its proximal end, the first surface of which is complementary and corresponds to a second surface comprising the distal end of the upper compartment (205) when the medication application is complete.
[0005]
Device according to claim 1, characterized in that the lower compartment (202) still comprises at least one window (204) in it, through which a distal end of the syringe (218) is visible.
[0006]
6. Device according to claim 1, characterized by the fact that it still comprises an assisted actuator (219) capable of applying a downward force in the upper compartment (205).
[0007]
7. Device according to claim 1, characterized by the fact that the upper compartment (205) still comprises a cylindrical sleeve in it and fixedly attached to it, in which the distal portion of the cylindrical sleeve is housed within the intermediate compartment (201 ), the distal portion including an assisted trigger.
[0008]
8. Device according to claim 1, characterized by the fact that the lower compartment (202) still comprises a controller (222) to indicate when the medication application is complete.
[0009]
9. Device according to claim 2, characterized by the fact that it still comprises a handle lock (224) that prevents the upper compartment (205) from moving in relation to the lower compartment (202), in which when the protection needle (208) has completed its upward movement, the needle guard (208) contacts the handle lock (224) causing the handle lock (224) to deflect outward, allowing the upper compartment (205) move down.
[0010]
10. Device according to claim 9, characterized by the fact that the handle lock (224) is part of the lower compartment (202).
[0011]
11. Device according to claim 3, characterized by the fact that it still comprises a needle protection lock that prevents the needle protection (208) from retracting after completing the application.
[0012]
12. Device for administering medication, the device characterized by the fact that it comprises: a lower compartment (102, 202) and a syringe (118, 218) supported by the lower compartment, the syringe having a needle (110, 210) attached to Is it over there; a plunger rod (115, 215); an upper compartment (101, 205) movably supported by the lower compartment (102, 202) and configured to move towards the lower compartment (102, 202) to cause the piston rod (115, 215) to move towards the syringe (118, 218) and eject the medication out of the needle (110, 210); and a changing element (119, 219) configured to provide a changing force that guides the upper compartment (101, 205) to move towards the lower compartment (102, 202), but does not cause the upper compartment ( 101, 205) move towards the lower compartment (102, 202) without the application of an additional force by a user, and the change force is configured to assist the additional force as the additional force is applied to the compartment upper (101, 205) towards the lower compartment (102, 202) in order to cause the upper compartment (101, 205) to move towards the lower compartment (102, 202).
[0013]
13. Device according to claim 12, characterized by the fact that the altering force of the altering element (119, 219) is adjusted in relation to the viscosity of the medication to be applied.
[0014]
14. Device (100, 200) for administering medication, the device characterized by the fact that it comprises: a lower compartment (102, 202) that supports a syringe (118, 218) having a needle (110, 210); a needle guard (108, 208) which is movable with respect to the lower compartment (102, 202) in order to expose the needle (110, 210); an upper compartment (101, 205) supported in relation to the lower compartment (102, 202), the upper compartment (101, 205) configured to receive a manual force and move in relation to the lower compartment (102, 202) along a direction in the direction of the needle (110, 210) from a first position to a second position in response to manual force; a plunger rod (115, 215) carried by the upper compartment (101, 205) and movable with the upper compartment (101, 205) in order to advance in relation to the syringe (118, 218) when the upper compartment (101, 205 )) is moved along the direction, where the advance of the plunger rod (115, 215) in relation to the syringe (118, 218) causes the syringe (118, 218) to distribute the medication out of the needle (110 , 210); and a lock (122, 224) that reliably interferes with the upper compartment (101, 205) when the upper compartment (101, 205) is in the first position so that there is an interference between the lock (122, 224) and the upper compartment (101, 205) prevents the upper compartment (101, 205) from moving towards the second position, where the movement of the needle guard (108, 208) in relation to the lower compartment (102, 202), in order to expose the needle (110, 210), it causes the interference to be removed, thus allowing the upper compartment (101, 205) to move from the first position to the second position.
[0015]
15. Device according to claim 14, characterized by the fact that it still comprises an intermediate compartment (201) coupled between the lower compartment (202) and the upper compartment (205), in which the intermediate compartment (201) includes a body (207) which is exposed when the upper compartment (205) is in the first position and covered by the upper compartment (205) when the upper compartment (205) is in the second position.
[0016]
16. Device according to claim 14, characterized by the fact that the needle guard (108, 208) carries a surface (133, 240) that contacts the lock (122, 224) and causes the lock (122 , 224) deviates away from interference with the upper compartment (101, 205) as the needle guard (108, 208) moves in relation to the lower compartment (102, 202) in order to expose the needle (110, 210) .
[0017]
17. Device according to claim 16, characterized by the fact that the lower compartment (202) carries the lock (122).
[0018]
18. Device for administering medication, the device characterized by the fact that it comprises: a lower compartment (102, 202) configured to support a syringe (118, 218) containing a medication in it and having a needle (210); an upper compartment (101, 205) supported in relation to the lower compartment (102, 202) and configured to move with respect to the lower compartment (102, 202) along a direction towards the needle (110, 210) of a first position to a second position; a plunger rod (115, 215) carried by the upper compartment (101, 205) and movable with the upper compartment (101, 205) in order to advance in relation to the syringe (118, 218) when the upper compartment (101, 205 )) is moved along the direction, where the advance of the plunger rod (115, 215) in relation to the syringe (118, 218) causes the syringe (118, 218) to distribute the medication out of the needle (110 , 210); and a locking element (117, 220) which is configured to lock the upper compartment (101, 205) in the second position, in order to prevent the upper compartment (101, 205) from moving from the second position towards the first position after the upper compartment (101, 205) has moved to the second position from the first position.
[0019]
19. Device according to claim 18, characterized by the fact that it still comprises an intermediate compartment (201) coupled between the lower compartment (202) and the upper compartment (205) so that the upper compartment (205) moves in relation to the intermediate compartment (201) when the upper compartment (205) moves from the first position to the second position.
[0020]
20. Device according to claim 19, characterized in that the locking element (220) is carried by the upper compartment (205) and the locking element (220) interferes with the middle compartment (201) in a way to prevent the locking element (220) from moving from the second position towards the first position after the upper compartment (205) has moved to the second position from the first position.
[0021]
21. Device according to claim 20, characterized by the fact that the locking element (220) creates a control sound when the locking element (220) is received by a capture slot (236).
[0022]
22. Device according to claim 18, characterized by the fact that it still comprises a needle guard (108, 208) that is configured to move in relation to the lower compartment (102, 202) to expose the needle (110, 210) when the lower compartment (102, 202) is pressed against the skin surface.
[0023]
23. Device according to claim 22, characterized by the fact that it still comprises a second locking element (122, 224) that intervenes reliably with the upper compartment (101, 205) when the upper compartment (101, 205 ) is in the first position so that interference between the second locking element (122, 224) and the upper compartment (101, 205) prevents the upper compartment (101, 205) from moving towards the second position, where the movement of the needle guard (108, 208) in relation to the lower compartment (102, 202) in order to expose the needle (110, 210), causes the interference to be removed, thus allowing the upper compartment (101, 205) move from the first position to the second position.

类似技术:

公开号 | 公开日 | 专利标题

BR112012008891B1|2021-04-13|DEVICE FOR ADMINISTRATION OF MEDICATION ACTIVATED WITH THE PALM OF THE HAND

JP6815370B2|2021-01-20|Palm-operated drug delivery device

AU2019203971B2|2020-10-22|Palm activated drug delivery device

AU2015201430B2|2016-06-16|Palm activated drug delivery device

BR122020006806B1|2022-02-08|DEVICE CONFIGURED TO ADMINISTER A DRUG

同族专利:

公开号 | 公开日

EA201500966A1|2016-07-29|

EA201890529A3|2018-11-30|

CA2777424A1|2011-04-21|

NZ705415A|2016-01-29|

CA3081980A1|2011-04-21|

IL261724A|2020-04-30|

US20160058955A1|2016-03-03|

IL249656A|2018-10-31|

JP6219353B2|2017-10-25|

EA201270565A1|2012-11-30|

EA031303B1|2018-12-28|

SG10201912277VA|2020-02-27|

CN102665805B|2017-12-08|

NZ599309A|2014-07-25|

CA3081934A1|2011-04-21|

AU2010306625B2|2015-01-22|

CA2777424C|2017-09-05|

EP2488237A2|2012-08-22|

US9216256B2|2015-12-22|

MX2012004446A|2012-06-08|

IN2012DN03239A|2015-10-23|

KR101805180B1|2018-01-10|

NZ626588A|2015-03-27|

KR20160148066A|2016-12-23|

US20110092915A1|2011-04-21|

KR20120095386A|2012-08-28|

CA2974411A1|2011-04-21|

EP2488237B1|2018-07-04|

EA037418B1|2021-03-25|

MX2019011493A|2019-11-01|

CN107715256A|2018-02-23|

EA023390B1|2016-05-31|

US10485931B2|2019-11-26|

JP2013508032A|2013-03-07|

NZ714959A|2016-09-30|

JP2016028731A|2016-03-03|

US20200054838A1|2020-02-20|

JP5886750B2|2016-03-16|

CN102665805A|2012-09-12|

CN107715256B|2020-08-14|

PT2488237T|2018-10-15|

IL261724D0|2018-10-31|

SG10201406636WA|2014-12-30|

BR112012008891A2|2020-05-12|

IL219130A|2017-01-31|

ES2680668T3|2018-09-10|

DK2488237T3|2018-08-27|

IL249656D0|2017-02-28|

PL2488237T3|2018-11-30|

WO2011047298A2|2011-04-21|

EA201890529A2|2018-07-31|

WO2011047298A3|2011-08-25|

EP3434305A1|2019-01-30|

CA2974411C|2020-09-22|

MX368328B|2019-09-27|

AU2010306625A1|2012-05-03|

IL219130D0|2012-06-28|

KR101763411B1|2017-07-31|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

BE755224A|1969-08-25|1971-02-24|Philips Nv|INJECTION SYRINGE|

DE2137405A1|1971-07-26|1973-02-08|Etimex Kunststoff|SPRAY FRAME|

GB9200219D0|1992-01-07|1992-02-26|Medimech Int Ltd|Automatic injectors|

US5271527A|1992-04-02|1993-12-21|Habley Medical Technology Corporation|Reusable pharmaceutical dispenser with full stroke indicator|

US5378233A|1992-11-18|1995-01-03|Habley Medical Technology Corporation|Selected dose pharmaceutical dispenser|

US5795336A|1993-02-11|1998-08-18|Beech Medical Products, Inc.|Automatic needle protector having features for facilitating assembly|

US5540664A|1993-05-27|1996-07-30|Washington Biotech Corporation|Reloadable automatic or manual emergency injection system|

UA10236A|1994-02-02|1996-12-25|Віктор Іванович Ємченко|Method for treatment of progressive myopia|

AU696439B2|1995-03-07|1998-09-10|Eli Lilly And Company|Recyclable medication dispensing device|

SE9502285D0|1995-06-22|1995-06-22|Pharmacia Ab|Improvements related to injections|

US5957896A|1997-08-11|1999-09-28|Becton, Dickinson And Company|Medication delivery pen|

FR2770404B1|1997-11-05|2000-01-28|Sedat|AUTOMATIC INJECTOR WITH NEEDLE RETRACTION AT THE END OF INJECTION|

DE19755125B4|1997-12-11|2006-04-20|Tecpharma Licensing Ag|Needle protection device for injection devices|

WO1999038554A1|1998-01-30|1999-08-05|Novo Nordisk A/S|An injection syringe|

US7455661B2|1998-04-17|2008-11-25|Becton, Dickinson And Company|Safety shield system for prefilled syringe|

DE19925904C1|1999-06-07|2001-02-01|Disetronic Licensing Ag|Unit for subcutaneous application of an injectable product comprises a system which indicates whether the protection sleeve of the injection needle is in its fully retracted position|

EP1200144A1|1999-07-30|2002-05-02|Medrad, Inc.|Injector systems and syringe adapters for use therewith|

US6613022B1|2000-05-05|2003-09-02|Safety Syringes, Inc.|Passive needle guard for syringes|

US6547764B2|2000-05-31|2003-04-15|Novo Nordisk A/S|Double pointed injection needle|

US6986760B2|2000-08-02|2006-01-17|Becton, Dickinson And Company|Pen needle and safety shield system|

US7419481B2|2000-10-13|2008-09-02|Alza Corporation|Apparatus and method for piercing skin with microprotrusions|

US6602222B1|2000-10-13|2003-08-05|Cambridge Biostability Ltd.|Disposable injection device|

CN100363063C|2001-11-09|2008-01-23|阿尔扎公司|Collapsible syringe cartridge|

US7004929B2|2002-03-29|2006-02-28|Mdc Investment Holdings, Inc.|Safety pre-filled cartridge injector|

US6808507B2|2002-05-10|2004-10-26|Cambridge Biostability Ltd.|Safety injectors|

CA2500195C|2002-09-24|2009-07-21|Shl Medical Ab|Injecting device|

WO2004047892A1|2002-11-25|2004-06-10|Tecpharma Licensing Ag|Injection apparatus comprising a needle-protecting device|

US7252651B2|2003-01-07|2007-08-07|Becton, Dickinson And Company|Disposable injection device|

US6805686B1|2003-05-06|2004-10-19|Abbott Laboratories|Autoinjector with extendable needle protector shroud|

WO2005009519A1|2003-07-31|2005-02-03|Sid Technologies Llc|Syringe with automatically triggered safety sleeve|

US7481818B2|2003-10-20|2009-01-27|Lifescan|Lancing device with a floating probe for control of penetration depth|

DE10351596B4|2003-11-05|2007-10-11|Tecpharma Licensing Ag|Autoinjector with variable dose|

DE10351599A1|2003-11-05|2005-06-16|Tecpharma Licensing Ag|Auto-injection device|

DK1703929T3|2003-12-18|2010-09-20|Tecpharma Licensing Ag|Detachable injection device|

PL1715903T3|2004-01-23|2008-03-31|The Medical House Plc|Injection device|

US20050222539A1|2004-03-30|2005-10-06|Pediamed Pharmaceuticals, Inc.|Automatic injection device|

EP3804789A1|2004-04-29|2021-04-14|AbbVie Inc.|Autoinjector with extendable needle protector shroud|

US7585287B2|2004-06-16|2009-09-08|Smiths Medical Md, Inc.|Device and method for insertion of a cannula of an infusion device|

KR20070117543A|2005-01-24|2007-12-12|앤태어스 파머, 인코퍼레이티드|Prefilled needle assisted jet injector|

DK2058020T3|2005-02-01|2013-01-07|Intelliject Inc|Device for administering drug|

DE102005007614A1|2005-02-18|2006-08-24|Tecpharma Licensing Ag|Auto-injector with a release lock|

FR2884722A1|2005-04-20|2006-10-27|Becton Dickinson France Soc Pa|INJECTION ASSEMBLY AND ASSISTANCE DEVICE|

FR2884721A1|2005-04-20|2006-10-27|Becton Dickinson France Soc Pa|Assistance device for device of injection of a product, comprises hollow body for receiving the product, hollow injection needle for penetrating into injection site, piston placed in the body, hollow sleeve with bearing surface|

JP5222722B2|2005-04-20|2013-06-26|ベクトン・ディキンソン・フランス・エス．エー．エス．|Infusion set and infusion aid|

DE102005023854B4|2005-05-24|2020-12-17|Tecpharma Licensing Ag|Dosing device for an injection device|

US7918824B2|2005-06-21|2011-04-05|Eli Lilly And Company|Needled pharmaceutical delivery device with triggered automatic needle insertion and manually controlled pharmaceutical injection|

JP4767655B2|2005-10-28|2011-09-07|テルモ株式会社|Protector and needle set|

US20070173770A1|2006-01-23|2007-07-26|The Medical House Plc|Injection device|

FR2905273B1|2006-09-06|2009-04-03|Becton Dickinson France Soc Pa|AUTOMATIC INJECTION DEVICE WITH TIMING MEANS.|

WO2008010738A2|2007-01-24|2008-01-24|Uros Babic|Patent foramen ovale occluder with suture based anchor|

US20080228147A1|2007-03-15|2008-09-18|Bristol-Myers Squibb Company|Injector for use with pre-filled syringes and method of assembly|

JP2009060982A|2007-09-04|2009-03-26|Suzuken Co Ltd|Syringe needle cartridge|

JP5654350B2|2007-09-25|2015-01-14|ベクトン・ディキンソン・フランス・エス．エー．エス．|Automatic injector equipped with a trigger that can be positioned at the operating position by movement of the safety shield and an indication of the operating position|

FR2926727B1|2008-01-28|2010-12-24|Becton Dickinson France|DEVICE FOR PROTECTING AN INJECTION APPARATUS, IN PARTICULAR A MEDICAL INJECTION APPARATUS SUCH AS A SERIGUE|

US7811261B2|2008-06-02|2010-10-12|Sta-Med, Llc|Needle cover assembly for a syringe|

DE102008037310A1|2008-08-11|2010-07-29|Tecpharma Licensing Ag|Automatic injection device for the administration of a fixed dose|

GB0907534D0|2009-05-01|2009-06-10|Owen Mumford Ltd|Injection devices|

AU329059S|2009-06-10|2009-12-24|Reckitt & Colman Overseas|Refill bottle|

AU329064S|2009-06-10|2009-12-24|Reckitt & Colman Overseas|Refill bottle|

GB0910681D0|2009-06-19|2009-08-05|Ucb Pharma Sa|Auto-injector|

EA023390B1|2009-10-16|2016-05-31|Янссен Байотек, Инк.|Palm activated drug delivery device|

US9233213B2|2009-10-16|2016-01-12|Janssen Biotech, Inc.|Palm activated drug delivery device|

JP5855022B2|2010-02-22|2016-02-09|サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング|Power transmission arrangement for automatic syringes|

WO2011109205A2|2010-03-01|2011-09-09|Eli Lilly And Company|Automatic injection device with delay mechanism including dual functioning biasing member|

US9352099B2|2010-07-02|2016-05-31|Sanofi-Aventis Deutschland Gmbh|Safety device for a pre-filled syringe and injection device|

JP5905002B2|2010-07-02|2016-04-20|サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング|Safety device for prefilled syringes and injection devices|

WO2012000834A1|2010-07-02|2012-01-05|Sanofi-Aventis Deutschland Gmbh|Safety device for a pre-filled syringe and injection device|

EP2646101B1|2010-12-02|2019-02-20|Erskine Medical LLC|Release mechanism for use with needle shielding devices|

GB201021764D0|2010-12-22|2011-02-02|Owen Mumford Ltd|Autoinjectors|

RU2013136400A|2011-01-04|2015-02-10|Санофи-Авентис Дойчланд Гмбх|PROTECTIVE DEVICE FOR PRELIMINARY FILLING SYRINGE AND INJECTION DEVICE|

RU2578376C2|2011-01-04|2016-03-27|Санофи-Авентис Дойчланд Гмбх|Protective device for pre-filled syringe and injection device|

AU2012210170B2|2011-01-24|2016-09-29|Elcam Medical Agricultural Cooperative Association Ltd.|Injector|

KR101853607B1|2011-01-24|2018-05-03|애브비 바이오테크놀로지 리미티드|Removal of needle shields from syringes and automatic injection devices|

BR112013025628B1|2011-04-05|2021-01-12|Shl Medical Ag|medicament delivery device comprising a locking mechanism with a lever|

KR101541662B1|2011-08-26|2015-08-03|일라이 릴리 앤드 캄파니|Refill module for an injection device|

AU353353S|2013-10-02|2014-01-21|Terumo Corp|Medical syringe|JP2628613B2|1990-07-31|1997-07-09|株式会社日立ビルシステム|Elevator intercom|

US9656019B2|2007-10-02|2017-05-23|Medimop Medical Projects Ltd.|Apparatuses for securing components of a drug delivery system during transport and methods of using same|

US20090093793A1|2007-10-02|2009-04-09|Yossi Gross|External drug pump|

US10420880B2|2007-10-02|2019-09-24|West Pharma. Services IL, Ltd.|Key for securing components of a drug delivery system during assembly and/or transport and methods of using same|

MX2010012691A|2008-05-20|2011-03-30|Avant Medical Corp Star|Autoinjector system.|

US8177749B2|2008-05-20|2012-05-15|Avant Medical Corp.|Cassette for a hidden injection needle|

US8052645B2|2008-07-23|2011-11-08|Avant Medical Corp.|System and method for an injection using a syringe needle|

EP3052166B1|2013-09-30|2019-04-17|Medimop Medical Projects Ltd.|Adhesive cover peeler and needle cover remover for autoinjector|

EA023390B1|2009-10-16|2016-05-31|Янссен Байотек, Инк.|Palm activated drug delivery device|

CN105228673B|2013-03-15|2019-05-31|詹森生物科技公司|Palm activated form drug delivery device|

US9233213B2|2009-10-16|2016-01-12|Janssen Biotech, Inc.|Palm activated drug delivery device|

WO2012000836A1|2010-07-02|2012-01-05|Sanofi-Aventis Deutschland Gmbh|Safety device for a pre-filled syringe and injection device|

GB201017363D0|2010-10-14|2010-11-24|Owen Mumford Ltd|Injection devices|

EP2468333A1|2010-12-21|2012-06-27|Sanofi-Aventis Deutschland GmbH|Auto-injector|

DK2699293T3|2011-04-20|2019-04-29|Amgen Inc|AUTO INJECTION DEVICE|

KR101566132B1|2011-06-17|2015-11-04|에스에이치엘 그룹 에이비|Injection device|

EP2572741A1|2011-09-23|2013-03-27|Sanofi-Aventis Deutschland GmbH|Medicament delivery device and actuation mechanism for a drug delivery device|

JP6424089B2|2011-11-07|2018-11-14|イーライリリーアンドカンパニー|Injection device with ergonomic improvement|

EP2601992A1|2011-12-08|2013-06-12|Sanofi-Aventis Deutschland GmbH|Syringe carrier|

EP2687251A1|2012-07-17|2014-01-22|Sanofi-Aventis Deutschland GmbH|Drug delivery device|

EP2687252A1|2012-07-17|2014-01-22|Sanofi-Aventis Deutschland GmbH|Drug delivery device|

EP2698179A1|2012-08-14|2014-02-19|Sanofi-Aventis Deutschland GmbH|Injection device|

EP2703029A1|2012-09-04|2014-03-05|Sanofi-Aventis Deutschland GmbH|Medicament delivery device with alignment mechanism|

DK2705861T3|2012-09-05|2015-07-20|Becton Dickinson France|Automatic injection device|

EP2716318A1|2012-10-04|2014-04-09|Sanofi-Aventis Deutschland GmbH|Medicament delivery device with medicament delivery initiation indicator|

KR101716593B1|2012-10-05|2017-03-27|케어베이 유럽 리미티드|Medicament delivery device|

JP6125187B2|2012-10-16|2017-05-10|テルモ株式会社|Liquid dosing device|

EP2946801B1|2013-01-15|2018-07-18|Terumo Kabushiki Kaisha|Liquid dispenser|

WO2014122782A1|2013-02-08|2014-08-14|テルモ株式会社|Pre-filled syringe|

JP6360470B2|2013-03-08|2018-07-18|テルモ株式会社|Liquid dosing device|

JP6480350B2|2013-03-13|2019-03-06|サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング|Assembly of drug delivery device including feedback function|

US10092703B2|2013-03-15|2018-10-09|Amgen Inc.|Drug cassette, autoinjector, and autoinjector system|

EP2781230B1|2013-03-22|2019-08-21|TecPharma Licensing AG|Substance dispensing device with a signaling device|

EP2823838A1|2013-07-09|2015-01-14|Sanofi-Aventis Deutschland GmbH|Autoinjector|

US20160151578A1|2013-07-17|2016-06-02|Sanofi|Drive assembly for a drug delivery device|

JP6104747B2|2013-07-25|2017-03-29|テルモ株式会社|Liquid dosing device|

WO2015057408A1|2013-10-03|2015-04-23|Jeff Baker|Medicament delivery and training cartridge system and mechanisms of actuation|

EP2868338A1|2013-10-31|2015-05-06|Sanofi-Aventis Deutschland GmbH|Medicament delivery device|

MX2016006213A|2013-11-13|2016-08-08|Genentech Inc|Assisted manual injector devices and methods.|

JP6473750B2|2013-11-22|2019-02-20|サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング|Drug delivery device with dose delivery clicker|

EP2878319A1|2013-11-28|2015-06-03|Sanofi-Aventis Deutschland GmbH|Boot remover|

AU2015209535B2|2014-01-21|2017-06-01|Parenteral Technologies, Llc|Force actuated injection device|

WO2015110327A1|2014-01-21|2015-07-30|Carebay Europe Ltd|Injector training device|

EP2902061A1|2014-01-30|2015-08-05|Sanofi-Aventis Deutschland GmbH|Medicament delivery device|

US9658518B2|2014-02-11|2017-05-23|Eskil Nordhaug|Video stabilization device and method|

US10155088B2|2014-03-04|2018-12-18|Merck Sharp & Dohme Corp.|Prefilled disposable injection device|

JP6262030B2|2014-03-11|2018-01-17|テルモ株式会社|Liquid dosing device|

JP6296840B2|2014-03-11|2018-03-20|テルモ株式会社|Liquid dosing device|

JP6262031B2|2014-03-11|2018-01-17|テルモ株式会社|Liquid dosing device|

EP3122173B1|2014-03-26|2021-03-31|SCR Engineers Ltd|Livestock location system|

JP6411097B2|2014-07-03|2018-10-24|テルモ株式会社|Prefilled syringe|

KR20170029592A|2014-08-15|2017-03-15|일라이 릴리 앤드 캄파니|Automatic medication injection device with visible indication of injecting progress|

CH710119A2|2014-09-03|2016-03-15|Tecpharma Licensing Ag|An injection device with a sequencer.|

US11071279B2|2014-09-05|2021-07-27|Intervet Inc.|Method and system for tracking health in animal populations|

US10986817B2|2014-09-05|2021-04-27|Intervet Inc.|Method and system for tracking health in animal populations|

MA41101A|2014-12-03|2017-10-10|Lilly Co Eli|AUTOMATIC DRUG INJECTION DEVICE WITH AUDIBLE INDICATION OF INJECTION PROGRESS|

AU2015100213B4|2015-02-23|2015-09-03|Turnbull, John MR|Large animal vacination / treatment gun|

US10149943B2|2015-05-29|2018-12-11|West Pharma. Services IL, Ltd.|Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly|

TW201700117A|2015-06-03|2017-01-01|賽諾菲阿凡提斯德意志有限公司|Syringe carrier for an autoinjector and method of assembling|

TW201705994A|2015-06-03|2017-02-16|賽諾菲阿凡提斯德意志有限公司|Autoinjector and method of assembling|

GB2542202A|2015-09-14|2017-03-15|Consort Medical Plc|Injection device|

US10086145B2|2015-09-22|2018-10-02|West Pharma Services Il, Ltd.|Rotation resistant friction adapter for plunger driver of drug delivery device|

US9987432B2|2015-09-22|2018-06-05|West Pharma. Services IL, Ltd.|Rotation resistant friction adapter for plunger driver of drug delivery device|

EP3380167A1|2015-11-27|2018-10-03|Sanofi-Aventis Deutschland GmbH|An injection device with slidable member for removing a cap with a needle shield|

CN108290012A|2015-12-08|2018-07-17|贝克顿迪金森法国两合公司|T shape caps for medical syringe|

CN108290008A|2015-12-08|2018-07-17|贝克顿迪金森法国两合公司|The cap with hemisphere portion for injector for medical purpose|

WO2017098435A1|2015-12-08|2017-06-15|Becton Dickinson France S.A.S.|Housing and cap for medical injector|

CN108367125B|2015-12-08|2022-01-25|贝克顿迪金森法国公司|Cap for medical syringe|

US10500351B2|2016-02-12|2019-12-10|Shawn Michael Michels|Aid for subcutaneous tissue injection and process of effecting the injection with the aid|

US10265476B2|2016-03-11|2019-04-23|Shl Medical Ag|Two body syringe carrier assembly with dampener|

US10376647B2|2016-03-18|2019-08-13|West Pharma. Services IL, Ltd.|Anti-rotation mechanism for telescopic screw assembly|

CH712739A2|2016-07-26|2018-01-31|Tecpharma Licensing Ag|Injection device with a cap and a device for preventing re-insertion of the cap.|

CN109562233A|2016-08-02|2019-04-02|赛诺菲-安万特德国有限公司|Drug delivery device|

GB201616712D0|2016-09-30|2016-11-16|Owen Mumford Ltd|Injection devices|

FR3056915B1|2016-10-04|2021-12-17|Aptar France Sas|MANUAL INJECTION DEVICE.|

FR3056916B1|2016-10-04|2018-11-09|Aptar France Sas|MANUAL INJECTION DEVICE.|

JP6856840B2|2016-12-27|2021-04-14|アクションメディカルテクノロジーズ，エルエルシーＡｃｔｉｏｎＭｅｄｉｃａｌＴｅｃｈｎｏｌｏｇｉｅｓ，Ｌｌｃ|Injector and how to operate the injector|

US20200121853A1|2017-03-15|2020-04-23|Owen Mumford Limited|An injection apparatus|

US20200282152A1|2017-09-29|2020-09-10|West Pharmaceutical Services, Inc.|Housing with syringe holding feature|

CN111372622A|2017-10-20|2020-07-03|西部制药服务有限公司|Semi-reusable syringe system|

CN111225696A|2017-11-10|2020-06-02|安进公司|Plunger for a drug delivery device|

KR101862679B1|2018-05-03|2018-05-31|박영오|Syringe kit for treating keloids|

CN112203705A|2018-05-29|2021-01-08|杨森制药公司|Cap for an injection device|

US11224696B2|2018-07-10|2022-01-18|Action Medical Technologies, Llc|Apparatuses and method for injecting medicaments|

US10675416B2|2018-08-17|2020-06-09|David Harold Kovacs|Retractable syringe|

WO2021050448A1|2019-09-09|2021-03-18|West Pharmaceutical Services, Inc.|Track and locking mechanisms for injection device|

CN111150906B|2020-02-24|2020-09-29|苏州恒瑞宏远医疗科技有限公司|Two-step automatic injection device|

US11065392B1|2020-03-25|2021-07-20|Action Medical Technologies, Llc|Apparatuses and methods for injecting medicaments|

WO2021198371A1|2020-04-03|2021-10-07|Sanofi|Injector device|

法律状态:
2020-05-26| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

2020-10-06| B07A| Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]|

2021-02-17| B09A| Decision: intention to grant|

2021-04-13| B16A| Patent or certificate of addition of invention granted|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF |

优先权:

申请号 | 申请日 | 专利标题

US25237809P| true| 2009-10-16|2009-10-16|

US61/252,378|2009-10-16|

US36198310P| true| 2010-07-07|2010-07-07|

US61/361,983|2010-07-07|

PCT/US2010/052894|WO2011047298A2|2009-10-16|2010-10-15|Palm activated drug delivery device|

[返回顶部]